Evaluation of periodontal status and interleukin levels in pregnant women with HELLP syndrome

Document Type : Original Article

Authors

1 Associate Professor, Department of Periodontology, Faculty of Dentistry, Van Yuzuncu Yil University, Van, Turkey

2 Associate Professor, Department of Obstetrics and Gynecology, Faculty of Medicine, Balikesir University, Balikesir, Turkey

3 Associate Professor, Department of Prosthodontics, Faculty of Dentistry, Nuh Naci Yazgan University, Kayseri, Turkey

4 Associate Professor, Department of Obstetrics and Gynecology, Faculty of Medicine, Yuzuncu Yil University, Van, Turkey

5 Department of Periodontology, Faculty of Dentistry, Van Yuzuncu Yil University, Van, Turkey

6 Professor, Department of Obstetrics and Gynecology, Faculty of Medicine, Yuzuncu Yil University, Van, Turkey

10.22122/johoe.2022.195326.1224

Abstract

BACKGROUND AND AIM: Hemolysis, elevated liver enzymes and low platelet (HELLP) syndrome is a pregnancy-specific disease that affects many systems of the body. Its etiopathogenesis has not been fully elucidated. HELLP syndrome is characterized by hemolysis, elevated liver enzymes, and low platelet counts. It has a prevalence of 0.2%-0.8% in pregnant women. This study aimed to compare periodontal status as well as interleukin (IL)-6 and IL-37 levels in gingival crevicular fluid (GCF) of healthy pregnant women and pregnant women with HELLP syndrome.
METHODS: This study included 20 patients with HELLP and 20 healthy pregnant women. The clinical periodontal parameters [plaque index (PI), gingival index (GI), bleeding on probing (BOP), probing depth (PD), clinical attachment level (CAL)] were recorded and GCF samples were collected. IL-6 and IL-37 levels were measured in GCF samples using the enzyme linked immunosorbent assay (ELISA) method. The data collected from healthy pregnant women and patients with HELLP were compared with statistical analysis.
RESULTS: There was no statistically significant difference between healthy pregnant women and pregnant women with HELLP in terms of periodontal clinical parameters. There was a statistically significant difference in terms of IL-6 levels (P < 0.05); however, no statistically significant difference was determined in terms of IL-37 levels in GCF.
CONCLUSION: This is the first study to evaluate periodontal status as well as IL-6 and IL-37 levels in GCF in pregnant women with HELLP syndrome. The results of the study showed that IL-6 levels were significantly higher in pregnant women with HELLP syndrome, but there was no significant difference in terms of other parameters. Further research is needed to evaluate the relationship between HELLP syndrome and periodontal disease.

Keywords


  1. Boggess KA. Maternal oral health in pregnancy. Obstet Gynecol 2008; 111(4): 976-86.
  2. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005; 366(9499): 1809-20.
  3. Offenbacher S, Katz V, Fertik G, Collins J, Boyd D, Maynor G, et al. Periodontal infection as a possible risk factor for preterm low birth weight. J Periodontol 1996; 67(Suppl 10S): 1103-13.
  4. Garcia RI, Henshaw MM, Krall EA. Relationship between periodontal disease and systemic health. Periodontol 2000 2001; 25: 21-36.
  5. Canakci V, Canakci CF, Canakci H, Canakci E, Cicek Y, Ingec M, et al. Periodontal disease as a risk factor for pre-eclampsia: A case control study. Aust N Z J Obstet Gynaecol 2004; 44(6): 568-73.
  6. Polyzos NP, Polyzos IP, Zavos A, Valachis A, Mauri D, Papanikolaou EG, et al. Obstetric outcomes after treatment of periodontal disease during pregnancy: Systematic review and meta-analysis. BMJ 2010; 341: c7017.
  7. Lokki AI, Haapio M, Heikkinen-Eloranta J. Eculizumab treatment for postpartum HELLP syndrome and aHUS-case report. Front Immunol 2020; 11: 548.
  8. Stojanovska V, Zenclussen AC. Innate and adaptive immune responses in HELLP syndrome. Front Immunol 2020; 11: 667.
  9. McCulloch CA. Host enzymes in gingival crevicular fluid as diagnostic indicators of periodontitis. J Clin Periodontol 1994; 21(7): 497-506.
  10. Kinney JS, Morelli T, Oh M, Braun TM, Ramseier CA, Sugai JV, et al. Crevicular fluid biomarkers and periodontal disease progression. J Clin Periodontol 2014; 41(2): 113-20.
  11. Barros SP, Williams R, Offenbacher S, Morelli T. Gingival crevicular fluid as a source of biomarkers for periodontitis. Periodontol 2000 2016; 70(1): 53-64.
  12. Becerik S, Ozturk VO, Atmaca H, Atilla G, Emingil G. Gingival crevicular fluid and plasma acute-phase cytokine levels in different periodontal diseases. J Periodontol 2012; 83(10): 1304-13.
  13. Saglam M, Koseoglu S, Savran L, Pekbagriyanik T, Saglam G, Sutcu R. Levels of interleukin-37 in gingival crevicular fluid, saliva, or plasma in periodontal disease. J Periodontal Res 2015; 50(5): 614-21.
  14. Li C, Zhao P, Sun X, Che Y, Jiang Y. Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with Guillain-Barre syndrome. Mediators Inflamm 2013; 2013: 639712.
  15. Ramfjord SP. Indices for prevalence and incidence of periodontal disease. J Periodontol 1959; 30(1): 51-9.
  16. Silness J, Loe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condtion. Acta Odontol Scand 1964; 22: 121-35.
  17. Loe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963; 21: 533-51.
  18. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J 1975; 25(4): 229-35.
  19. Demir SC, Evruke C, Ozgunen FT, Urunsak IF, Candan E, Kadayifci O. Factors that influence morbidity and mortality in severe preeclampsia, eclampsia and hemolysis, elevated liver enzymes, and low platelet count syndrome. Saudi Med J 2006; 27(7): 1015-8.
  20. Ingec M, Kumtepe Y, Borekçi B, Bebek Z, Kadanali S. Maternal and perinatal outcomes of 81 cases of eclampsia in 2001-2003. Jinekoloji ve Obstetrik Dergisi 2005; 19(3):135-41. [In Turkish].
  21. Gunes ON. Serum zinc and cu levels in patients with HELLP syndrome. [Thesis]. Ataturk, Turkey: Ataturk University; 2014. [In Turkish].
  22. Tulmac OB. Hypertensive Disorders in Pregnancy; Definition, Classification and Pathophysiology. Kirikkale Üniversitesi Tip Fakültesi Dergisi 2012; 14(2): 17-23. [In Turkish].
  23. Reubinoff BE, Schenker JG. HELLP syndrome--a syndrome of hemolysis, elevated liver enzymes and low platelet count--complicating preeclampsia-eclampsia. Int J Gynaecol Obstet 1991; 36(2): 95-102.
  24. Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol 1990; 162(2): 311-6.
  25. Sibai BM, Taslimi MM, el-Nazer A, Amon E, Mabie BC, Ryan GM. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986; 155(3): 501-9.
  26. Stone JH. HELLP syndrome: Hemolysis, elevated liver enzymes, and low platelets. JAMA 1998; 280(6): 559-62.
  27. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982; 142(2): 159-67.
  28. Boggess KA, Lieff S, Murtha AP, Moss K, Beck J, Offenbacher S. Maternal periodontal disease is associated with an increased risk for preeclampsia. Obstet Gynecol 2003; 101(2): 227-31.
  29. Canakci V, Canakci CF, Yildirim A, Ingec M, Eltas A, Erturk A. Periodontal disease increases the risk of severe pre-eclampsia among pregnant women. J Clin Periodontol 2007; 34(8): 639-45.
  30. Chambrone L, Guglielmetti MR, Pannuti CM, Chambrone LA. Evidence grade associating periodontitis to preterm birth and/or low birth weight: I. A systematic review of prospective cohort studies. J Clin Periodontol 2011; 38(9): 795-808.
  31. Ha JE, Jun JK, Ko HJ, Paik DI, Bae KH. Association between periodontitis and preeclampsia in never-smokers: A prospective study. J Clin Periodontol 2014; 41(9): 869-74.
  32. Khader YS, Jibreal M, Al-Omiri M, Amarin Z. Lack of association between periodontal parameters and preeclampsia. J Periodontol 2006; 77(10): 1681-7.
  33. Haeger M, Unander M, Andersson B, Tarkowski A, Arnestad JP, Bengtsson A. Increased release of tumor necrosis factor-alpha and interleukin-6 in women with the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Acta Obstet Gynecol Scand 1996; 75(8): 695-701.
  34. Tranquilli AL, Landi B, Corradetti A, Giannubilo SR, Sartini D, Pozzi V, et al. Inflammatory cytokines patterns in the placenta of pregnancies complicated by HELLP (hemolysis, elevated liver enzyme, and low platelet) syndrome. Cytokine 2007; 40(2): 82-8.
  35. Wallace K, Morris R, Kyle PB, Cornelius D, Darby M, Scott J, et al. Hypertension, inflammation and T lymphocytes are increased in a rat model of HELLP syndrome. Hypertens Pregnancy 2014; 33(1): 41-54.
  36. Ozler A, Turgut A, Sak ME, Evsen MS, Soydinc HE, Evliyaoglu O, et al. Serum levels of neopterin, tumor necrosis factor-alpha and Interleukin-6 in preeclampsia: Relationship with disease severity. Eur Rev Med Pharmacol Sci 2012; 16(12): 1707-12.
  37. Ganap EP, Sofoewan S, Siswosudarmo R. Comparison of serum interleukin-6 (Il-6) levels between patients with HELLP syndrome versus normotensive pregnant. Sains Medika 2018; 9(2): 62-6.
  38. Ebersole JL. Humoral immune responses in gingival crevice fluid: Local and systemic implications. Periodontol 2000 2003; 31: 135-66.
  39. van Runnard Heimel PJ, Kavelaars A, Heijnen CJ, Peters WH, Huisjes AJ, Franx A, et al. HELLP syndrome is associated with an increased inflammatory response, which may be inhibited by administration of prednisolone. Hypertens Pregnancy 2008; 27(3): 253-65.
  40. Torrance HL, Krediet TG, Vreman HJ, Visser GH, van BF. Oxidative stress and proinflammatory cytokine levels are increased in premature neonates of preeclamptic mothers with HELLP syndrome. Neonatology 2008; 94(2): 138-42.
  41. Boraschi D, Lucchesi D, Hainzl S, Leitner M, Maier E, Mangelberger D, et al. IL-37: A new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw 2011; 22(3): 127-47.
  42. Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA. IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol 2010; 11(11): 1014-22.
  43. Tete S, Tripodi D, Rosati M, Conti F, Maccauro G, Saggini A, et al. IL-37 (IL-1F7) the newest anti-inflammatory cytokine which suppresses immune responses and inflammation. Int J Immunopathol Pharmacol 2012; 25(1): 31-8.
  44. Boggess KA, Berggren EK, Koskenoja V, Urlaub D, Lorenz C. Severe preeclampsia and maternal self-report of oral health, hygiene, and dental care. J Periodontol 2013; 84(2): 143-51.
  45. Zhu X, Ma Y, Sang H, Wang L, He M. Expression of interleukin-37 in placenta and its relationship with the pathogenesis of severe preeclampsia. Zhonghua Fu Chan Ke Za Zhi 2015; 50(5): 341-5. [In Chinese].
  46. Talmac AC, Calisir M, Eroglu EG, Ertugrul AS. Effects of Er, Cr: YSGG and diode lasers on clinical parameters and gingival crevicular fluid IL-1beta and IL-37 levels in generalized aggressive periodontitis. Mediators Inflamm 2019; 2019: 2780794.
  47. Desai K, Desai P, Duseja S, Kumar S, Mahendra J, Duseja S. Significance of maternal periodontal health in preeclampsia. J Int Soc Prev Community Dent 2015; 5(2): 103-7.
  48. Oettinger-Barak O, Barak S, Ohel G, Oettinger M, Kreutzer H, Peled M, et al. Severe pregnancy complication (preeclampsia) is associated with greater periodontal destruction. J Periodontol 2005; 76(1): 134-7.
  49. Varshney S, Gautam A. Poor periodontal health as a risk factor for development of pre-eclampsia in pregnant women. J Indian Soc Periodontol 2014; 18(3): 321-5.
  50. Shetty MS, Ramesh A, Shetty PK, Agumbe P. Salivary and serum antioxidants in women with preeclampsia with or without periodontal disease. J Obstet Gynaecol India 2018; 68(1): 33-8.
  51. Kunnen A, van Doormaal JJ, Abbas F, Aarnoudse JG, van Pampus MG, Faas MM. Periodontal disease and pre-eclampsia: A systematic review. J Clin Periodontol 2010; 37(12): 1075-87.